Rasha Aboelhassan: How Much Should We Depend on AI as Oncologists?
Rasha Aboelhassan/LinkedIn

Rasha Aboelhassan: How Much Should We Depend on AI as Oncologists?

Rasha Aboelhassan, Senior Oncology Consultant at Nasser Institute Hospital, shared a post on LinkedIn:

How much should we depend on AI as an oncologist?

As a physician, I’ve always believed that growth means learning new tools – but never at the expense of core skills.

AI is becoming part of our daily practice, and we must learn how to use it.

But this paper was a wake-up call:

It shows that repeated reliance on AI can quietly erode our clinical judgment and independent thinking.

While AI improves efficiency and short-term performance, it may also contribute to clinical deskilling – the gradual erosion of our diagnostic reasoning and independent judgment.

For me, the message is clear:

AI should support our decisions – not replace the way we think.

Because the real risk is not that AI makes mistakes…

It’s that one day, we stop noticing them.”

Title: Artificial intelligence in medicine: a scoping review of the risk of deskilling and loss of expertise among physicians

Authors: Pierre Heudel,  H. Crochet, Q. Filori, T. Bachelot1, J.Y. Blay

Read the article.

Rasha Aboelhassan

Other articles featuring Rasha Aboelhassan on OncoDaily.